Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle

Eur J Intern Med. 2022 Jul:101:37-38. doi: 10.1016/j.ejim.2022.04.018. Epub 2022 Apr 25.

Authors

Nicola Farina¹, Lorenzo Dagna²

Affiliations

¹ Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: farina.nicola@hsr.it.
² Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: dagna.lorenzo@unisr.it.

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Humans
Interleukin-6

Substances

Interleukin-6